Advertisement

International Journal of Clinical Pharmacy

, Volume 40, Issue 3, pp 580–588 | Cite as

Herbal medicine use among Type 2 diabetes mellitus patients in Nigeria: understanding the magnitude and predictors of use

  • Ogochukwu Ukamaka Amaeze
  • Roseline Iberi Aderemi-Williams
  • Modupeola Anuoluwapo Ayo-Vaughan
  • Deborah Aderoju Ogundemuren
  • Damilola Segun Ogunmola
  • Emmanuel Nwanolue Anyika
Research Article

Abstract

Background Patients with chronic diseases exploit complementary and alternative treatment options to manage their conditions better and improve well-being. Objective To determine the prevalence and predictors of herbal medicine use among Type 2 Diabetes patients in Lagos, Nigeria. Setting Secondary healthcare facilities in Lagos state, Nigeria. Method The study design was a cross sectional survey. A two-stage sampling approach was used to select the health facilities and patients were recruited consecutively to attain the sample size. Data was collected using a structured and standardized interviewer-administered questionnaire. Characteristics, prevalence and predictors of herbal medicine use were assessed using descriptive statistics and multivariate regression analyses. Main outcome measure Herbal medicine use among Type 2 diabetes mellitus patients. Results 453 patients were surveyed, 305 (67.3%) reported herbal medicine use, among whom 108 (35.4%) used herbal and conventional medicines concurrently; 206 (67.5%) did not disclose use to their physician. Herbal medicine use was significantly associated with age (p = 0.045), educational level (p = 0.044), occupation (p = 0.013), duration of diabetes disease (p = 0.007), mode of diabetes management (p = 0.02), a positive history of diabetes (p = 0.011) and presence of diabetes complication (p = 0.033). Formulations or whole herbs of Vernonia amygdalina, Moringa oleifera, Ocimum gratissimum, Picralima nitida, and herbal mixtures were the commonest herbal medicine. Beliefs and perceptions about herbal medicine varied between the users and non-users. Conclusion The use of herbal medicine among Type 2 diabetes mellitus patients in Lagos, Nigeria is high. There is dire need for health care practitioners to frequently probe patients for herbal medicine use and be aware of their health behaviour and choices, with a view to manage the disease better.

Keywords

Diabetes mellitus Herbal medicines Herbal medicines use Nigeria Predictors Prevalence 

Notes

Acknowledgements

The authors sincerely appreciate all the patients who took part in this study. We also thank the administrative staff and nurses in the five health facilities that assisted in maintaining orderliness with the respondents during the interviews.

Funding

The research was funded by the authors.

Conflicts of interest

The authors declare no conflicts of interest.

References

  1. 1.
    World Health Organisation. WHO global status report on non-communicable diseases 2014. http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf?ua=1. Accessed 06 Nov 2017.
  2. 2.
    International Diabetes Federation. IDF Diabetes Atlas, 7th edn. Brussels, Belsium: IDF, 2015. http://www.diabetesatlas.org/resources/2015-atlas.html. Accessed 21 Oct 2017.
  3. 3.
    Alebiosu OC, Familoni OB, Ogunsemi OO, Raimi TH, Balogun WO, Odusan O, et al. Community based diabetes risk assessment in Ogun state, Nigeria (World Diabetes Foundation Project 08-321). Indian J Endocrinol Metab. 2013;17(4):653–8.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: a review of current trends. Oman Med J. 2012;27(4):269–73.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Mbanya JC, Assah FK, Saji J, Atanga EN. Obesity and Type 2 diabetes mellitus in sub-Sahara Africa. Curr Diab Rep. 2014;14:501.CrossRefPubMedGoogle Scholar
  6. 6.
    Idemyor V. Diabetes in sub-Saharan Africa: health care perspectives, challenges and the economic burden of disease. J Natl Med Assoc. 2010;102(7):650–3.CrossRefPubMedGoogle Scholar
  7. 7.
    Algothamy AS, Alruqayb WS, Abdallah MA, Mohamed KM, Albarraq AA. Prevalence of using herbal drugs as anti-diabetic agents in Taif Area, Kingdom of Saudi Arabia. Saudi J Health Sci. 2016;3(3):137–40.Google Scholar
  8. 8.
    World Health Organisation. WHO Traditional Medicine Strategy: 2014-2023. http://apps.who.int/iris/bitstream/10665/92455/1/9789241506090_eng.pdf. Accessed 20 Mar 2017.
  9. 9.
    Leach MJ, Lauche R, Zhang AL, Cramer H, Adams J, Langhorst J, Dobos G. Characteristics of herbal medicine users among internal medicine patinets: a crosss-sectional analysis. J Herb Med. 2017.  https://doi.org/10.1016/j.hermed.2017.06.005.CrossRefGoogle Scholar
  10. 10.
    Tulunay M, Aypak C, Yikilkan H, Gorpelioglu S. Herbal medicine use among patients with chronic diseases. J Intercult Ethnopharmacol. 2015;4(3):217–20.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Wu C, Wang C, Tsai M, Huang W, Kennedy J. Trend and pattern of herb and supplement use in the United States: results from the 2007 and 2012 National health interview surveys. Evid Based Complement Altern Med. 2002.  https://doi.org/10.1155/2014/872320.CrossRefGoogle Scholar
  12. 12.
    Oreagba IA, Oshikoya KA, Amachree M. Herbal medicine use among urban residents in Lagos, Nigeria. BMC Complement Altern Med. 2011.  https://doi.org/10.1186/1472-6882-11-117.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Awodele O, Amagon KI, Usman SO, Obasi PC. Safety of herbal medicines use: case study of Ikorodu residents in Lagos, Nigeria. Curr Drug Saf. 2014;9:138–44.CrossRefPubMedGoogle Scholar
  14. 14.
    Achigbu EO, Achigbu KI. Traditional medication use among out-patients attending the eye clinic of a Secondary health facility in Owerri South-East Nigeria. Orient J Med. 2014;62(3–4):107–13.Google Scholar
  15. 15.
    Onyeka TC, Ezike HA, Nwoke OM, Onyia EA, Onuorah EC, Anya SU, Nnacheta TA. Herbal medicine: a survey of use in Nigerian presurgical patients booked for ambulatory anaesthesia. BMC Complement Altern Med. 2012; 12:30. http://www.biomedcentral.com/1472-6882/12/130.
  16. 16.
    Nwako OS, Fakeye TO. Evaluation of use of herbal medicines among ambulatory hypertensive patients attending a Secondary healthcare facility in Nigeria. Int J Pharm Pract. 2009;17(2):101–5.CrossRefGoogle Scholar
  17. 17.
    Fakeye TO, Adisa R, Ismail ME. Attitude and use of herbal medicines among pregnant women in Nigeria. BMC Complement Altern Med. 2009;9:53.  https://doi.org/10.1186/1472-6882-9-53.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Alami Z, Aynaou H, Alami B, Hdidou Y, Latrech H. Herbal medicines use among diabetic patients in Oriental Morocco. J Pharmacogn Phyther. 2015;7(2):9–17.CrossRefGoogle Scholar
  19. 19.
    Jegede A, Oladosu P, Ameh S, Kolo I, Izebe K, Builders P, et al. Status of management of diabetes mellitus by traditional medicine practitioners in Nigeria. J Med Plants Res. 2011;5(27):6309–15.CrossRefGoogle Scholar
  20. 20.
    Mwangi J, Gitonga L. Perceptions and use of herbal remedies among patients with diabetes mellitus in Murang’a North District, Kenya. Open J Clin Diagn. 2014;4:152–72.CrossRefGoogle Scholar
  21. 21.
    Ogbera A, Dada O, Adeleye F, Jewo P. Complementary and alternative medicine use in diabetes mellitus. West Afr J Med. 2010;29(3):158–61.PubMedGoogle Scholar
  22. 22.
    Quandt SA, Verhoef MJ, Arcury TA, Lewith GT, Steinsbekk A, Kristoffersen AE, et al. Development of an international questionnaire to measure use of complementary and alternative medicine (I-CAM-Q). J Altern Complement Med. 2009;15(4):331–9.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Ali BAM, Mohamed MS. Herbal medicine use among patients with Type 2 diabetes in North Sudan. Annu Res Rev Biol. 2014;4(11):1827–38.CrossRefGoogle Scholar
  24. 24.
    Al-garni AM, Al-Raddadi RM, Al-Amri TA. Patterns and determinants of complementary and alternative medicine use among Type 2 diabetic patients in a diabetic center in Saudi Arabia. J Fundam Appl Sci. 2017;19(1S):1738–48.Google Scholar
  25. 25.
    Baldé NM, Youla A, Baldé MD, Kaké A, Diallo MM, Baldé MA, Maugendre D. Herbal medicine and treatment of diabetes in Africa: an example from Guinea. Diabetes Metab. 2006;32(2):171–5.CrossRefPubMedGoogle Scholar
  26. 26.
    Chang HA, Wallis M, Tiralongo E. Use of complementary and alternative medicine among people with Type 2 diabetes in Taiwan: a Cross-sectional survey. Evid Based Complement Altern Med. 2011.  https://doi.org/10.1155/2011/983792.CrossRefGoogle Scholar
  27. 27.
    Ching SM, Zakaria ZA, Paimin F, Jalalian M. Complementary alternative medicine use among patients with Type 2 diabetes mellitus in the primary care setting : a cross-sectional study in. BMC Complement Altern Med. 2013;13:148.  https://doi.org/10.1186/1472-6882-13-148.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Medagama AB, Bandara R, Abeysekera RA, Imbulpitiya B, Pushpakumari T. Use of complementary and alternative medicines (CAMs) among type 2 diabetes patients in Sri Lanka: a cross sectional survey. BMC Complement Altern Med. 2014; 14:374. http://www.biomedcentral.com/1472-6882/14/374.
  29. 29.
    Bell RA, Suerken CK, Grzwacz JG, Lang W, Quandt SA, Arcury TA. Complementary and alternative medicine use among adults with diabetes in the United States. Altern Ther Health Med. 2006;12(5):16–22.PubMedGoogle Scholar
  30. 30.
    Khalaf AJ, Whitford DL. The use of complementary and alternative medicines by patients with diabetes mellitus in Bahrain: a cross-sectional study. BMC Complement Atern Med. 2010;10:35. http://www.biomedcentral.com/1472-6882/10/35.
  31. 31.
    Singh J, Singh R, Gautam CS. Self-medication with herbal remedies amongst patients of type 2 diabetes mellitus: a preliminary study. Indian J Endocrinol Metab. 2012;16(4):662–3.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Tarirai C, Viljoen AM, Hamman JH. Herb–drug interactions reviewed. Expert Opin Drug Metab Toxicol. 2010;6(12):1515–38.CrossRefPubMedGoogle Scholar
  33. 33.
    Izzo AA. Interactions between herbs and conventional drugs: overview of the clinical data. Med Princ Pract. 2012;21(5):404–28.CrossRefPubMedGoogle Scholar
  34. 34.
    Ezuruike UF, Prieto JM. The use of plants in the traditional management of diabetes in Nigeria: pharmacological and toxicological considerations. J Ethnopharmacol. 2014;155(2):857–924.CrossRefPubMedGoogle Scholar
  35. 35.
    Borokini TI, Ighere DA, Clement M, Ajiboye TO, Alowonle AA. Ethnobiological survey of traditional medicine practice for the treatment of piles and diabetes mellitus in Oyo State. J Med Plants Stud. 2013;1:30–40.Google Scholar
  36. 36.
    Arowosegbe S, Olanipekun MK, Kayode J. Ethnobotanical survey of medicinal plants used for the treatment of diabetes mellitus in Ekiti Souh Senatorial District, Nigeria. Eur J Bot Plant Sci Phytol. 2015;2(4):1–8.Google Scholar
  37. 37.
    Kadiri M, Ojewumi AW, Agboola DAAM. Research article ethnobotanical survey of plants used in the management of diabetes mellitus in Abeokuta, Nigeria. J drug Deliv Ther. 2015;5(3):13–23.Google Scholar
  38. 38.
    Ofuegbe SO, Adedapo AA. Ethnomedicinal survey of some plants used for the treatment of diabetes in Ibadan, Nigeria. Asian J Med Sci. 2015;6(5):36–40.CrossRefGoogle Scholar
  39. 39.
    Chikezie PC, Ojiako OA, Nwufo KO. Overview of anti-diabetic medicinal plants: the Nigerian research experience. J Diabetes Metab. 2015;6:546.  https://doi.org/10.4172/2155-6156.1000546.CrossRefGoogle Scholar
  40. 40.
    Okolie UV, Okeke CE, Oli JM, Ehiemere IO. Hypoglycaemic indices of Vernonia amygdalina on postprandial blood glucose concentration of healthy humans. Afr J Biotechnol. 2008;7(24):4581–5.Google Scholar
  41. 41.
    Oguanobi NI, Paschal Chijioke C, Ghasi S. Anti-diabetic effect of crude leaf extracts of ocimum gratissimum in neonatal streptozotocin-induced type-2 model diabetic rats. Int J Pharm Pharm Sci. 2012;4(Suppl 5):77–83.Google Scholar
  42. 42.
    Ezeigbo OR, Barrah CS, Ezeigbo IC. Phytochemical Analysis and antidiabetic effect of aqueous and ethanolic extracts of Moringa oleifera leaves in alloxan-induced diabetic wistar albino rats using insulin as reference drug. Int J Diabetes Res. 2016;5(3):48–53.Google Scholar
  43. 43.
    Hussain SS, Khalid HE, Ahmed SM, Technologies A. Anti-diabetic activity of the leaves of Moringa oleifera Lam. growing in Sudan on streptozotocin-induced diabetic rats. Br J Med Heal Res. 2016;3(4):48–57.Google Scholar
  44. 44.
    Aguwa CN, Ukwe CV, Inya-Agha SI, Okonta JM. Antidiabetic effect of picralima nitida aqueous seed extract in experimental rabbit model. J Nat Remedies. 2001;1(2):135–9.Google Scholar
  45. 45.
    Suleiman KA. Attitudes and beliefs of consumers of herbal medicines in Riyadh, Saudi Arabia. J Community Med Health Educ. 2013;4(2):2–7.CrossRefGoogle Scholar
  46. 46.
    Al-Rowais NA. Herbal medicine in the treatment of diabetes mellitus. Saudi Med J. 2002;23:1237–41.Google Scholar
  47. 47.
    Wazaify M, Afifi FU, El-Khateeb M, Ajlouni K. Complementary and alternative medicine use among Jordanian patients with diabetes. Complement Ther Clin Pract. 2011;17(2):71–5.CrossRefPubMedGoogle Scholar
  48. 48.
    Egede LE, Ye X, Zheng D, Silverstein MD. The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care. 2002;25(2):324–9.CrossRefPubMedGoogle Scholar
  49. 49.
    Huri HZ, Lian GTP, Hussain S, Pendek S, Widodo RT. A survey amongst complementary and alternative medicine users with Type 2 diabetes. Int J Diabetes Metab. 2009;17:9–15.Google Scholar
  50. 50.
    Arcury TA, Bell RA, Snively BM, Smith SL, Skelly AH, Wetmore LK, Quandt SA. Complementary and alternative medicine use as health self-management: rural older adults with diabetes. J Gerontol B Psychol Sci Soc Sci. 2006;61:S62–70.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Ogochukwu Ukamaka Amaeze
    • 1
  • Roseline Iberi Aderemi-Williams
    • 1
  • Modupeola Anuoluwapo Ayo-Vaughan
    • 1
  • Deborah Aderoju Ogundemuren
    • 1
  • Damilola Segun Ogunmola
    • 1
  • Emmanuel Nwanolue Anyika
    • 1
  1. 1.Department of Clinical Pharmacy and Biopharmacy, Faculty of PharmacyUniversity of LagosLagosNigeria

Personalised recommendations